A case of coexistent angiosarcoma and follicular carcinoma of the thyroid. by Kim, Na Rae et al.
INTRODUCTION
High-grade neoplasms of the thyroid with an angiomatoid
appearance by light microscopy have been debated for about
100 yr (1), and have not yet been included into the latest World
Health Organization (WHO) classification of the thyroid (2).
Several authors have described such tumors that display both
anaplastic carcinoma and pseudoangiosarcomatous appearance,
making difficult the inclusion of these tumors in either the
anaplastic carcinoma of the thyroid or conventional angiosar-
coma groups of the WHO classification. However, angiosar-
coma generally represents a rare connective tissue tumor of the
thyroid, and has been designated as malignant hemangioen-
dothelioma by many authors (3, 4), and rarely occurs in that
organ. We described a case of an angiosarcoma and well dif-
ferentiated follicular carcinoma with intervening transitional
area. The present report will provide an additional evidence
that angiosarcoma of the thyroid is a specific condition of en-
dothelial origin, which is different from angiosarcoma-like
anaplastic carcinoma. Here, to confirm the nature of the pre-
sent tumor, immunohistochemistry and ultrastructural exam-
ination were done.
CASE REPORT
A 64-yr-old-man was admitted due to a painless mass in
the anterior region of the neck that had been rapidly growing
for several months. 99mTc thyroid scan showed a cold defect in
the right lobe of the thyroid. The results of thyroid function
tests were within the normal ranges. He has a history of right
pneumonectomy for tuberculosis about 20 yr ago. Fine needle
aspiration cytology of the thyroid showed atypical cells show-
ing nuclear pleomorphism and anaplasia, which were sugges-
tive of anaplastic carcinoma. Careful examinations using radi-
ologic methods as well as nuclear medicine did not disclose
any metastatic or primary foci, and the tumor was confined
within the thyroid region. The patient underwent total thy-
roidectomy. Two months later, slight dyspnea developed. Skull
radiography showed multinodular osteolytic lesions and chest
computed tomography showed multifocal bilateral scattered
nodules, implying metastatic tumor nodules. He refused fur-
ther evaluation. Chemotherapy and local radiation therapy
were scheduled, but he was lost to follow-up.
Grossly, the right lobe and left lobe measured 8×5×3 cm,
and 6×3×2 cm. Each weighed 56 g and 20 g. The external
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A Case of Coexistent Angiosarcoma and Follicular Carcinoma of the
Thyroid
Angiosarcoma of the thyroid has long been a controversial entity, and it is histologi-
cally defined as cleft-like anastosmosing spaces lined by large, atypical cells of
endothelial lineage. However, clear-cut separation between the angiosarcoma
and anaplastic carcinoma of the thyroid is difficult because they yield nearly the
same clinical prognosis and overlapping histologic findings. We report a case of
thyroid neoplasm composed of minimally invasive well differentiated follicular carci-
noma and angiosarcoma with intervening transitional area. Immunohistochemically,
the angiosarcomatous portion showed focal immunoreactivity for endothelial mark-
ers such as CD31, CD34, Ulex europaeus 1 lectin, factor VIII-related antigen, and
immunonegativity for epithelial markers including pancytokeratin, epithelial membrane
antigen and thyroglobulin, whereas the reverse was demonstrated in the minimally
invasive follicular carcinomatous portion. The follicular carcinoma portion was pos-
itive for thyroid transcription factor-1 (TTF-1). Each component showed ultrastruc-
tural findings of epithelial and endothelial differentiation, respectively. The present
case was unique in that angiosarcoma of the thyroid was confirmed by immunohis-
tochemistry and electron microscopy, as well as light microscopy, and also coexist-
ed with a minimally invasive well differentiated follicular carcinoma in the same mass.
This combination has never been described in the literature. Although restricted to
a single case, the present case further supports that angiosarcoma is a true exis-
tent entity rather than a variant of anaplastic carcinoma.
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surface of each lobe was smooth, glistening with beefy red
appearance. The cut surface showed a bulging solid hemor-
rhagic dark red mass, measuring 4.8×3.2×2.5 cm, at the
lower pole of the right lobe (Fig. 1). It was confined within
the thyroid gland. During operation, a frozen diagnosis was
required and a poorly differentiated malignant tumor was
diagnosed. The specimen was fixed in 10% neutral formalin,
and then embedded in paraffin. Immunohistochemistry was
done by an avidin-biotin-peroxidase complex method. Anti-
bodies against the following antigens were used: pancyto-
keratin (AE1/AE3, Dako, Glostrup, Denmark, 1:80 dilution),
epithelial membrane antigen (E29, Dako, 1:50 dilution),
thyroglobulin (DAK-Tg6, Dako, 1:80 dilution), thyroid tran-
scription factor-1 (TTF-1, 8G7G3/1, Dako, 1:50 dilution),
calcitonin (Cal3-F5, Dako, 1:1,200 dilution), vimentin (Dako,
1:80 dilution), CD31 (JC/70A, Dako, 1:20 dilution), CD34
(QBEnd 10, Dako, 1:100 dilution), Ulex europaeus 1 lectin
(Ventana, prediluted), factor VIII-related antigen (BioGene-
sis, Poole, U.K., 1:150 dilution). Microscopically, the tumor
was composed of microfollicles with extensive hemorrhage in
the center of the tumor. These follicular carcinomatous por-
tion was composed predominantly of a solid microfollicular
growth pattern with capsular invasion (Fig. 2A, B), and the
tumor cells were relatively uniform sized nuclei that were slight-
ly hyperchromatic. In other area of the mass, there were anas-
tomosing channels lined by atypical neoplastic cells of a high
nuclear-cytoplasmic ratio with occasional multinucleated bizarre
morphology (Fig. 2C). Atypical mitoses were also found in
up to 3 per 10 consecutive ×400 magnification. These areas
resembled epithelioid angiosarcoma, and capsular invasion
of angiosarcomatous components were also found (Fig. 2D).
At the mixed areas between the two, extensive hemorrhage
with stromal hyalinization was found (Fig. 2E). Immunohis-
tochemically, tumor cells of microfollicles were reactive for
pancytokeratin, TTF-1 (Fig. 3A) and thyroglobulin. Colloid
accumulation of follicular lumen was reactive for thyroglobu-
lin, while they were negative for calcitonin or vimentin. An-
giosarcomatous portion showed immunoreactivities for Ulex
europaeus 1 lectin, CD31 (Fig. 3B), CD34, and total negativ-
ities for pancytokeratin, TTF-1, or thyroglobulin. Less than
1% of tumor cells of the angiosarcomatous area were positive
for factor VIII-related antigen. Both follicular carcinomatous
and angiosarcomatous areas of paraffin block were taken for
ultrastructural examination. They were deparaffinated and
fixed in 2.5% glutaraldehyde, followed by 1% osmium with
propylene dioxide and finally embedded in Epok 812 (Oken
Shoji Ltd., Tokyo, Japan). The thick sections (1  m) were
stained with toluidine blue and Azure B solution to ascertain
that the desired cells were in the block. Thin sections were
poststained with uranyl acetate and lead citrate and examined
with a transmission scanning electron microscope (H-7100,
Hitachi High-Technologies, Tokyo, Japan) at an accelerating
voltage of 75 kv. Electron microscopy revealed that oval tumor
cells in the follicular carcinomatous and angiosarcomatous
components were outlined by basal lamina (Fig. 4A). The
tumor cells had follicular lumina with microvillous processes,
rounded nuclei, lysosomal dense bodies in the cytoplasm and
well-formed desmosomes. Those findings were compatible
with follicular epithelial glandular differentiation. In contrast,
portions microdissected from angiosarcomatous and undif-
ferentiated areas in the intervening transitional zone showed
endothelial differentiation, i.e. frequent basal laminae, junc-
tional complexes of the zonula adherens type between tumor
cells. The cytoplasm contained moderate amounts of pinocy-
totic vesicles (Fig. 4B), usually oriented along the plasma mem-
brane and microfilaments were also seen (Fig. 4C). Weibel-
Palade bodies were not found in the tumor cells. The diagno-
sis was coexistent angiosarcoma and minimally invasive fol-
licular carcinoma.
DISCUSSION
Angiosarcoma of the thyroid is rare and is composed of cleft-
like anastomosing spaces lined by large, atypical endothelial
cells. The differential diagnosis includes pseudoangiosarcoma-
tous carcinoma of the thyroid, which shows artifactual spaces
made in acantholytic/adenomatoid squamous carcinoma, i.e.
accumulation of hyaluonic acid in the stroma of the tumors
leading to the formation of the spaces (5). Pseudoangiosarco-
matous carcinomas share light microscopic features with an-
giosarcoma, but lack of immunoreactivity for endothelial
markers or ultrastructural evidence of endothelial differentia-
tion can distinguish the former from true angiosarcoma. Ultra-
structural endothelial differentiation has been said to be diag-
Fig. 1. The cut surface of the thyroid shows a well demarcated
bulging, variegated and hemorrhagic dark red lesion.910 N.R. Kim, Y.-H. Ko, C.O. Sung 
nostic for angiosarcoma; the presence of dilated cisternae of
endoplasmic reticulum, pinocytotic vesicles, Weibel-Palade
bodies and basal lamina (6). However, the concept of angiosar-
coma in the thyroid has long been a matter of debate because
some authors believe that most, if not all, angiosarcomas are
in fact “angiomatoid” anaplastic carcinomas. In Alpine region
of Central Europe, where adenomatous goiter is prevalent rang-
ing up to 16% of all thyroid lesions (7), vascular or pseudovas-
cular thyroid neoplasm is also common (2). Although both
anaplastic carcinoma and angiosarcoma take nearly the same
grave prognosis, and their distinction and investigation of their
origin is even regarded as an academic interest, the concept of
angiosarcoma of the thyroid has changed and is still changing
(4). Some authors proposed that the origin of angiosarcoma
of the thyroid be as endothelial lineage (8), and others regard-
ed it as poorly differentiated epithelial malignancies for diver-
gent endothelial differentiation (9, 10). Advances in immuno-
histochemistry has brought more confusion to this controver-
sial entity. Pfaltz et al. (11) categorized angiomatoid neoplasms
into three groups; classic angiosarcomas, borderline tumors
Fig. 2. (A) Follicular neoplasmic portion is composed of small, closely packed follicles of benign cytoarchitecture. Arrow indicates capsu-
lar invasion (H&E stain, ×40). (B) High magnification of capsular invasion (H&E stain, ×100). (C) Anastomosing racemoce-like vascular
channels lined by atypical endothelial cells showing occasional multinucleated cells are present in angiosarcomatous portion (H&E stain,
×200). (D) Capsular invasion of angiosarcomatous components (arrow, inset) is also found (H&E stain, ×100). (Fig. 2 continued next)
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showing angiosarcoma and anaplastic carcinoma, anaplastic
carcinoma with an angiosarcoma like growth pattern. Imm-
unoreactivity for endothelial markers as factor VIII-related
antigen was 60%, 21%, and 0%, respectively. They explained
that some borderline cases with a positivity for Ulex europaeus
1 lectin and a negativity for factor VIII-related antigen seem
to be a sign of dedifferentiation and may cause a decrease in
the production of factor VIII-related antigen. These immuno-
histochemical results well corresponded to the sensitive mark-
er of Ulex europaeus 1 lectin and specific marker of factor VIII-
related antigen (12, 13). However, considering immunohis-
tochemical heterogeneity of angiosarcomatoid neoplasm of
the thyroid, these immunohistochemical findings simply doc-
ument the phenotype of the tumor, and does not equate with
the definition of the cellular origin (9, 14, 15). In our opin-
ion, it is more reasonable that the mass should be diagnosed
as angiosarcoma admixed with well differentiated follicular
carcinoma rather than anaplastic carcinoma or sarcomatoid
carcinoma with angiosarcomatous differentiation, because
there was neither histological anaplasia in follicular carcinoma
portion nor cytokeratin-reactivity in angiosarcoma portion.
The concept of angiomatoid thyroid neoplasm including
angiosarcoma have shared histologic findings with ordinary
anaplastic carcinomas (16); cleft-like spaces lined by malignant
cells showing nuclear atypia and mitotic activity can be found
in the latter. Other findings include some portions showing
stromal papillae with hyalinized cores and extensive stromal
hemorrhage and erythrophagocytosis. Necrosis and stromal
hemosiderins are typical in angiomatoid thyroid neoplasm.
Occasionally, angiomatous foci merge with a solid sheet like
growth pattern, or spindle cell areas simulating those seen
in pure spindle cell anaplastic carcinomas or a small focus of
well differentiated typical papillary carcinoma adjacent to the
high-grade component, as is often the case with ordinary ana-
plastic carcinomas (17). Mills et al. (18) proposed that many
of the tumors diagnosed as angiosarcoma of the thyroid may
Fig. 2. (Continued from the previous page) (E) Mixed area shows scat-
tered microfollicles of the follicular carcinoma (left), which are mixed
with angiosarcoma (right, H&E stain, ×200).
Fig. 3. (A) Well differentiated follicular carcinoma portion shows nuclear and cytoplasmic immunoreactivity for TTF-1. Note totally negative
reaction of intervening angiosarcoma at the transitional area (TTF-1 immunostain, ×400). (B) Bizarre lining cells of angiosarcoma portion
are strongly positive for CD31 (CD31 immunostain, ×400).
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be pseudoangiosarcomatous carcinomas even in cases express-
ing focal immunoreactivity for endothelial markers because
the uptake of antigen-rich serum by tumor cells may cause
immunoreactivity for factor VIII-related antigen. In such cir-
cumstances, angiosarcoma can be distinguished from it by
recent molecular techniques and immunohistochemistry for
TTF-1; a weak signal for thyroglobulin mRNA was present
in all anaplastic carcinoma but not in angiosarcoma of the
thyroid, confirming that anaplastic carcinoma and angiosar-
coma of the thyroid are unrelated malignant tumors (8, 19).
Immunohistochemical staining for TTF-1 has been used to
identify pulmonary non-small cell carcinomas or well differ-
entiated follicular and papillary carcinomas of the thyroid (20).
The present case differs from the aberrant expression of endothe-
lial markers in that the spaces are lined by neoplastic cells
showing true endothelial differentiation, supported by posi-
tive reaction for more specific endothelial markers, i.e. CD31
and CD34 as well as ultrastructural evidence of endothelial
lineage. In the viewpoint of cellular origin, our case showed
that only follicular carcinomatous portion exhibited nuclear
and cytoplasmic expression for TTF-1, suggesting that angio-
sarcoma of the thyroid is an independent tumor different from
pseudosarcomatous or anaplastic carcinoma or follicular car-
cinoma. However, on the pathogenesis, there still remains
remote possibility that the two tumors have originated from
common progenitor cells, bidirectionally differentiating into
endothelial and follicular epithelial lineage. Several supporting
facts are as follows; first, rare aberrant expression of cytokeratin
Fig. 4. (A) Electron microscopy shows oval tumor cells surrounded
by continuous basal lamina (arrow) (original magnification ×3,500,
bar represents 519 nm). (B) The cytoplasm contains a moderate
amount of pinocytotic vesicles (arrow), usually oriented along the
plasma membrane (original magnification ×7,000, bar represents
259 nm). Inset indicates pinocytotic vesicles (original magnification
×50,000, bar represents 36 nm). (C) Abundant intracytoplasmic
10 nm sized intermediate filaments are arranged (original magni-
fication ×40,000, bar represents 65 nm).
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in angiosarcoma in other organs has occasionally been report-
ed because embryonic endothelial cells may express keratin
(2, 21, 22). Second, the light microscopic presence of areas of
well differentiated cells is observed in close vicinity to anaplas-
tic cells, i.e. so-called “transforming areas” (23).
The present case postulates that angiosarcoma of the thy-
roid is a distinctive entity, not same as anaplastic carcinoma
or angiomatoid thyroid neoplasm.
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